Compare IMPP & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMPP | SWKH |
|---|---|---|
| Founded | 1981 | 1996 |
| Country | Greece | United States |
| Employees | 49 | 9 |
| Industry | Marine Transportation | Diversified Financial Services |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.6M | 198.4M |
| IPO Year | N/A | N/A |
| Metric | IMPP | SWKH |
|---|---|---|
| Price | $4.97 | $16.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 543.0K | 104.8K |
| Earning Date | 05-22-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $51.79 | N/A |
| Revenue Next Year | $6.97 | N/A |
| P/E Ratio | ★ $3.68 | $9.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.45 | $13.86 |
| 52 Week High | $6.57 | $17.90 |
| Indicator | IMPP | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 55.38 | 32.19 |
| Support Level | $4.10 | $14.69 |
| Resistance Level | $5.26 | $17.08 |
| Average True Range (ATR) | 0.23 | 0.37 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 47.42 | 12.06 |
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.